Trade Vaxart, Inc. - VXRT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.06 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Vaxart Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.66 |
Open* | 0.67 |
1-Year Change* | -36.19% |
Day's Range* | 0.66 - 0.68 |
52 wk Range | 0.56-1.59 |
Average Volume (10 days) | 795.59K |
Average Volume (3 months) | 15.61M |
Market Cap | 116.66M |
P/E Ratio | -100.00K |
Shares Outstanding | 152.04M |
Revenue | 4.16M |
EPS | -0.64 |
Dividend (Yield %) | N/A |
Beta | 0.73 |
Next Earnings Date | Mar 13, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 0.68 | 0.02 | 3.03% | 0.66 | 0.68 | 0.66 |
Dec 7, 2023 | 0.66 | -0.01 | -1.49% | 0.67 | 0.68 | 0.66 |
Dec 6, 2023 | 0.66 | -0.03 | -4.35% | 0.69 | 0.69 | 0.66 |
Dec 5, 2023 | 0.68 | -0.01 | -1.45% | 0.69 | 0.70 | 0.66 |
Dec 4, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.70 | 0.69 |
Dec 1, 2023 | 0.70 | 0.01 | 1.45% | 0.69 | 0.70 | 0.67 |
Nov 30, 2023 | 0.69 | 0.01 | 1.47% | 0.68 | 0.72 | 0.68 |
Nov 29, 2023 | 0.67 | -0.01 | -1.47% | 0.68 | 0.70 | 0.67 |
Nov 28, 2023 | 0.69 | 0.00 | 0.00% | 0.69 | 0.70 | 0.67 |
Nov 27, 2023 | 0.70 | 0.02 | 2.94% | 0.68 | 0.71 | 0.67 |
Nov 24, 2023 | 0.69 | 0.01 | 1.47% | 0.68 | 0.70 | 0.67 |
Nov 22, 2023 | 0.69 | -0.04 | -5.48% | 0.73 | 0.74 | 0.69 |
Nov 21, 2023 | 0.73 | -0.02 | -2.67% | 0.75 | 0.75 | 0.72 |
Nov 20, 2023 | 0.75 | 0.00 | 0.00% | 0.75 | 0.82 | 0.75 |
Nov 17, 2023 | 0.77 | 0.00 | 0.00% | 0.77 | 0.78 | 0.76 |
Nov 16, 2023 | 0.77 | -0.05 | -6.10% | 0.82 | 0.83 | 0.74 |
Nov 15, 2023 | 0.81 | 0.08 | 10.96% | 0.73 | 0.85 | 0.73 |
Nov 14, 2023 | 0.74 | 0.06 | 8.82% | 0.68 | 0.74 | 0.68 |
Nov 13, 2023 | 0.69 | -0.03 | -4.17% | 0.72 | 0.72 | 0.66 |
Nov 10, 2023 | 0.72 | 0.03 | 4.35% | 0.69 | 0.72 | 0.67 |
Vaxart, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, March 13, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q4 2023 Vaxart Inc Earnings Release Q4 2023 Vaxart Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 0.107 | 0.892 | 4.046 | 9.862 | 4.159 |
Revenue | 0.107 | 0.892 | 4.046 | 9.862 | 4.159 |
Total Operating Expense | 107.734 | 69.855 | 34.216 | 25.747 | 19.155 |
Selling/General/Admin. Expenses, Total | 29.386 | 21.89 | 15.202 | 6.187 | 6.681 |
Research & Development | 81.054 | 48.749 | 19.863 | 14.54 | 17.275 |
Depreciation / Amortization | |||||
Interest Expense (Income) - Net Operating | |||||
Operating Income | -107.627 | -68.963 | -30.17 | -15.885 | -14.996 |
Interest Income (Expense), Net Non-Operating | 1.241 | 0.08 | 0.062 | -0.198 | -1.032 |
Other, Net | -1.305 | -1.48 | -1.874 | -2.073 | -1.859 |
Net Income Before Taxes | -107.691 | -70.363 | -31.982 | -18.155 | -17.898 |
Net Income After Taxes | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Net Income Before Extra. Items | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Net Income | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Income Available to Common Excl. Extra. Items | -107.758 | -70.47 | -32.22 | -18.645 | -18.346 |
Income Available to Common Incl. Extra. Items | -107.758 | -70.47 | -32.22 | -18.645 | -18.346 |
Diluted Net Income | -107.758 | -70.47 | -32.22 | -18.645 | -18.346 |
Diluted Weighted Average Shares | 127.684 | 121.454 | 88.2958 | 21.5695 | 6.31607 |
Diluted EPS Excluding Extraordinary Items | -0.84394 | -0.58022 | -0.36491 | -0.86441 | -2.90466 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | -0.85772 | -0.58442 | -0.37116 | -0.71317 | -3.39761 |
Gain (Loss) on Sale of Assets | 0 | 0.001 | -0.011 | ||
Total Extraordinary Items | |||||
Total Adjustments to Net Income | 0 | 0 | -0.339 | ||
Unusual Expense (Income) | -2.706 | -0.784 | -0.849 | 5.02 | -4.801 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1.358 | 0.675 | 0.022 | 0 | 0 |
Revenue | 1.358 | 0.675 | 0.022 | 0 | 0 |
Total Operating Expense | 24.411 | 26.247 | 24.2 | 29.426 | 29.247 |
Selling/General/Admin. Expenses, Total | 5.598 | 6.625 | 6.447 | 6.96 | 9.321 |
Research & Development | 18.813 | 19.622 | 20.459 | 22.466 | 19.926 |
Unusual Expense (Income) | -2.706 | ||||
Operating Income | -23.053 | -25.572 | -24.178 | -29.426 | -29.247 |
Interest Income (Expense), Net Non-Operating | 0.71 | 0.639 | 0.593 | 0.458 | 0.155 |
Other, Net | -0.188 | -0.178 | -0.317 | -0.325 | -0.323 |
Net Income Before Taxes | -22.531 | -25.111 | -23.902 | -29.293 | -29.415 |
Net Income After Taxes | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Net Income Before Extra. Items | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Net Income | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Income Available to Common Excl. Extra. Items | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Income Available to Common Incl. Extra. Items | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Diluted Net Income | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Diluted Weighted Average Shares | 139.594 | 135.213 | 131.612 | 126.89 | 126.428 |
Diluted EPS Excluding Extraordinary Items | -0.16154 | -0.18593 | -0.18173 | -0.23098 | -0.23278 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.16154 | -0.18593 | -0.1951 | -0.23098 | -0.23278 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 99.451 | 169.167 | 128.531 | 17.598 | 14.645 |
Cash and Short Term Investments | 95.717 | 166.487 | 126.87 | 13.526 | 11.506 |
Cash & Equivalents | 30.834 | 70.978 | 60.005 | 13.526 | 11.506 |
Short Term Investments | 49.704 | 22.742 | 0 | ||
Total Receivables, Net | 0.02 | 0.071 | 0.334 | 3.619 | 1.796 |
Accounts Receivable - Trade, Net | 0 | 3.619 | 0 | ||
Prepaid Expenses | 3.714 | 2.609 | 1.327 | 0.453 | 1.343 |
Total Assets | 153.847 | 221.168 | 152.582 | 37.032 | 35.227 |
Property/Plant/Equipment, Total - Net | 41.3 | 19.769 | 8.318 | 2.2 | 1.066 |
Property/Plant/Equipment, Total - Gross | 44.572 | 21.074 | 8.891 | 2.636 | |
Accumulated Depreciation, Total | -3.272 | -1.305 | -0.573 | -1.57 | |
Total Current Liabilities | 17.921 | 10.783 | 11.763 | 9.174 | 7.475 |
Accounts Payable | 5.514 | 3.872 | 2.133 | 0.852 | 0.962 |
Accrued Expenses | 8.444 | 5.339 | 6.219 | 5.406 | 1.407 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.095 | 0.836 | 2.779 | 2.916 | 1.667 |
Other Current Liabilities, Total | 3.868 | 0.736 | 0.632 | 3.439 | |
Total Liabilities | 43.25 | 33.637 | 29.178 | 24.08 | 23.989 |
Total Long Term Debt | 5.621 | 10.686 | 12.15 | 13.416 | 1.944 |
Long Term Debt | 5.621 | 10.686 | 12.15 | 13.416 | 1.944 |
Other Liabilities, Total | 19.708 | 12.168 | 5.265 | 1.49 | 14.57 |
Total Equity | 110.597 | 187.531 | 123.404 | 12.952 | 11.238 |
Common Stock | 0.013 | 0.013 | 0.011 | 4.825 | 0.714 |
Additional Paid-In Capital | 437.992 | 406.943 | 272.274 | 124.788 | 108.513 |
Retained Earnings (Accumulated Deficit) | -327.109 | -219.351 | -148.881 | -116.661 | -97.989 |
Other Equity, Total | -0.299 | -0.074 | |||
Total Liabilities & Shareholders’ Equity | 153.847 | 221.168 | 152.582 | 37.032 | 35.227 |
Total Common Shares Outstanding | 134.199 | 125.594 | 110.271 | 48.255 | 7.14119 |
Intangibles, Net | 5.02 | 10.624 | 15.361 | 17.093 | 19.413 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Other Long Term Assets, Total | 3.568 | 0.89 | 0.372 | 0.141 | 0.103 |
Cash | 15.179 | 72.767 | 66.865 | ||
Goodwill, Net | 4.508 | 4.508 | |||
Long Term Investments | 0 | 16.21 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 57.1 | 71.261 | 75.83 | 99.451 | 120.38 |
Cash and Short Term Investments | 53.037 | 67.905 | 71.811 | 95.717 | 114.767 |
Cash | 5.263 | 5.245 | 10.255 | 15.179 | 19.895 |
Cash & Equivalents | 27.975 | 38.032 | 38.179 | 30.834 | 30.873 |
Short Term Investments | 19.799 | 24.628 | 23.377 | 49.704 | 63.999 |
Total Receivables, Net | 0.424 | 0.029 | 0.264 | 0.02 | 0 |
Accounts Receivable - Trade, Net | 0.424 | 0.029 | 0.264 | 0 | |
Prepaid Expenses | 3.639 | 3.327 | 3.755 | 3.714 | 5.613 |
Total Assets | 105.642 | 122.653 | 129.851 | 153.847 | 175.309 |
Property/Plant/Equipment, Total - Net | 38.679 | 40.722 | 42.216 | 41.3 | 38.887 |
Property/Plant/Equipment, Total - Gross | 44.621 | 45.832 | 46.382 | 44.572 | 41.498 |
Accumulated Depreciation, Total | -5.942 | -5.11 | -4.166 | -3.272 | -2.611 |
Intangibles, Net | 4.472 | 4.654 | 4.837 | 5.02 | 9.611 |
Long Term Investments | 0 | 0 | |||
Other Long Term Assets, Total | 0.883 | 1.508 | 2.46 | 3.568 | 1.923 |
Total Current Liabilities | 11.268 | 13.883 | 15.683 | 17.921 | 21.74 |
Accounts Payable | 1.339 | 4.199 | 3.882 | 5.514 | 7.916 |
Accrued Expenses | 7.931 | 7.409 | 7.23 | 8.444 | 9.876 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.656 | 1.346 | 3.694 | 3.868 | 2.617 |
Total Liabilities | 34.121 | 37.58 | 40.098 | 43.25 | 53.002 |
Total Long Term Debt | 4.633 | 4.869 | 4.997 | 5.621 | 11.027 |
Other Liabilities, Total | 18.22 | 18.828 | 19.418 | 19.708 | 20.235 |
Total Equity | 71.521 | 85.073 | 89.753 | 110.597 | 122.307 |
Common Stock | 0.015 | 0.015 | 0.014 | 0.013 | 0.013 |
Additional Paid-In Capital | 463.755 | 459.912 | 442.068 | 437.992 | 426.003 |
Retained Earnings (Accumulated Deficit) | -392.199 | -374.799 | -352.249 | -327.109 | -303.191 |
Other Equity, Total | -0.011 | -0.024 | -0.07 | -0.299 | -0.518 |
Total Liabilities & Shareholders’ Equity | 105.642 | 122.653 | 129.851 | 153.847 | 175.309 |
Total Common Shares Outstanding | 152.037 | 151.983 | 135.597 | 134.199 | 128.331 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Goodwill, Net | 4.508 | 4.508 | 4.508 | 4.508 | 4.508 |
Current Port. of LT Debt/Capital Leases | 1.342 | 0.929 | 0.877 | 0.095 | 1.331 |
Long Term Debt | 4.633 | 4.869 | 4.997 | 5.621 | 11.027 |
Treasury Stock - Common | -0.039 | -0.031 | -0.01 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Cash From Operating Activities | -94.779 | -59.832 | -23.75 | -13.09 | -14.548 |
Cash From Operating Activities | 5.805 | 4.208 | 2.71 | 3.596 | 3.203 |
Non-Cash Items | 13.872 | 8.55 | 2.955 | 0.677 | -2.194 |
Changes in Working Capital | -6.698 | -2.12 | 2.805 | 1.282 | 2.45 |
Cash From Investing Activities | -20.415 | -49.097 | -1.22 | -0.85 | 26.212 |
Capital Expenditures | -9.601 | -5.157 | -1.223 | -0.85 | -0.707 |
Other Investing Cash Flow Items, Total | -10.814 | -43.94 | 0.003 | 0 | 26.919 |
Cash From Financing Activities | 17.462 | 125.804 | 138.314 | 15.96 | -1.729 |
Financing Cash Flow Items | 0 | 0.652 | |||
Issuance (Retirement) of Debt, Net | 0 | 0 | -3.799 | -1.742 | |
Net Change in Cash | -97.732 | 16.875 | 113.344 | 2.02 | 9.935 |
Cash Interest Paid | 0 | 0 | 0 | 0.227 | 0.356 |
Issuance (Retirement) of Stock, Net | 17.462 | 125.804 | 137.662 | 19.759 | 0.013 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.14 | -107.758 | -83.84 | -54.531 | -25.101 |
Cash From Operating Activities | -24.46 | -94.779 | -65.627 | -51.012 | -25.113 |
Cash From Operating Activities | 2.062 | 5.805 | 3.915 | 2.352 | 1.131 |
Non-Cash Items | 2.264 | 13.872 | 11.017 | 7.132 | 3.435 |
Changes in Working Capital | -3.646 | -6.698 | 3.281 | -5.965 | -4.578 |
Cash From Investing Activities | 25.461 | -20.415 | -36.216 | -5.143 | 3.732 |
Capital Expenditures | -1.239 | -9.601 | -10.738 | -3.672 | -1.346 |
Other Investing Cash Flow Items, Total | 26.7 | -10.814 | -25.478 | -1.471 | 5.078 |
Cash From Financing Activities | 1.42 | 17.462 | 8.866 | 3.878 | 1.04 |
Issuance (Retirement) of Stock, Net | 1.43 | 17.462 | 8.866 | 3.878 | 1.04 |
Net Change in Cash | 2.421 | -97.732 | -92.977 | -52.277 | -20.341 |
Financing Cash Flow Items | -0.01 | ||||
Cash Interest Paid | 0 | ||||
Issuance (Retirement) of Debt, Net |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Cantor Fitzgerald, L.P | Investment Advisor | 4.663 | 7086341 | 7086341 | 2023-06-30 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.5367 | 6894401 | -169485 | 2023-06-30 | LOW |
Millennium Management LLC | Hedge Fund | 1.4106 | 2143638 | 2067766 | 2023-06-30 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2459 | 1893422 | -5968529 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0324 | 1568909 | -1093564 | 2023-06-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.5212 | 792005 | 735548 | 2023-06-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.4933 | 749684 | 270134 | 2023-06-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.4867 | 739643 | -253580 | 2023-06-30 | LOW |
Finney Michael J | Individual Investor | 0.4414 | 670840 | 7375 | 2023-06-26 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3466 | 526745 | -2126874 | 2023-06-30 | LOW |
Rokos Capital Management LLP | Hedge Fund | 0.329 | 500000 | 500000 | 2023-06-30 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 0.2985 | 453670 | -1839853 | 2023-06-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.286 | 434690 | -21186 | 2023-06-30 | MED |
Susquehanna International Group, LLP | Investment Advisor | 0.2608 | 396311 | 324032 | 2023-06-30 | MED |
Cubist Systematic Strategies, LLC | Hedge Fund | 0.2314 | 351661 | 341109 | 2023-06-30 | HIGH |
Goldman Sachs & Company, Inc. | Research Firm | 0.2259 | 343288 | 254141 | 2023-06-30 | MED |
XTX Markets LLC | Venture Capital | 0.2197 | 333829 | 333829 | 2023-06-30 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.1708 | 259516 | -721867 | 2023-06-30 | MED |
IHT Wealth Management, LLC | Investment Advisor | 0.1692 | 257128 | -4095 | 2023-06-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.156 | 237116 | -773984 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Vaxart Company profile
Vaxart Inc. is a clinical-stage biotechnology company headquartered in San Francisco, California. It works on the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. It also has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company’s proprietary oral vaccine platform for the Janssen universal influenza vaccine program.
Vaxart is traded on the Nasdaq under the ticker VXRT. In its finance for Q4 2021, the company reported revenue totalling $0.89m, a 77.9% decrease from the $4.04m result in 2020.
Industry: | Bio Therapeutic Drugs |
170 Harbor Way, Suite 300
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com